Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals: results from the German Hepatitis C-Registry
ObjectiveChronic hepatitis C virus infection is associated with a significant health burden. Long-term consequences are the development of liver cirrhosis and hepatocellular carcinoma. The introduction of direct-acting antivirals (DAA) has led to an increase in sustained virologic response rates (SV
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
February 2019
|
| In: |
European journal of gastroenterology & hepatology
Year: 2019, Jahrgang: 31, Heft: 2, Pages: 230-240 |
| ISSN: | 1473-5687 |
| DOI: | 10.1097/MEG.0000000000001283 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1097/MEG.0000000000001283 |
| Verfasserangaben: | Kathrin Krüger, Christian Krauth, Siegbert Rossol, Stefan Mauss, Klaus Boeker, Tobias Müller, Hartwig Klinker, Anita Pathil, Renate Heyne, Jona Stahmeyer, and Collaborators DHC-R |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1677699833 | ||
| 003 | DE-627 | ||
| 005 | 20230427002425.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190925s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/MEG.0000000000001283 |2 doi | |
| 035 | |a (DE-627)1677699833 | ||
| 035 | |a (DE-599)KXP1677699833 | ||
| 035 | |a (OCoLC)1341244234 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Krüger, Kathrin |d 1976- |e VerfasserIn |0 (DE-588)129677809 |0 (DE-627)477117201 |0 (DE-576)297781863 |4 aut | |
| 245 | 1 | 0 | |a Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals |b results from the German Hepatitis C-Registry |c Kathrin Krüger, Christian Krauth, Siegbert Rossol, Stefan Mauss, Klaus Boeker, Tobias Müller, Hartwig Klinker, Anita Pathil, Renate Heyne, Jona Stahmeyer, and Collaborators DHC-R |
| 264 | 1 | |c February 2019 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 29.11.2019 | ||
| 520 | |a ObjectiveChronic hepatitis C virus infection is associated with a significant health burden. Long-term consequences are the development of liver cirrhosis and hepatocellular carcinoma. The introduction of direct-acting antivirals (DAA) has led to an increase in sustained virologic response rates (SV | ||
| 700 | 1 | |a Pathil-Warth, Anita |d 1981- |e VerfasserIn |0 (DE-588)132644304 |0 (DE-627)524715890 |0 (DE-576)260118915 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of gastroenterology & hepatology |d Hagerstown, Md. : Lippincott Williams & Wilkins, 1989 |g 31(2019), 2, Seite 230-240 |h Online-Ressource |w (DE-627)324743343 |w (DE-600)2030291-5 |w (DE-576)094835683 |x 1473-5687 |7 nnas |a Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals results from the German Hepatitis C-Registry |
| 773 | 1 | 8 | |g volume:31 |g year:2019 |g number:2 |g pages:230-240 |g extent:11 |a Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals results from the German Hepatitis C-Registry |
| 856 | 4 | 0 | |u https://doi.org/10.1097/MEG.0000000000001283 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190925 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 132644304 |a Pathil-Warth, Anita |m 132644304:Pathil-Warth, Anita |d 910000 |d 910100 |e 910000PP132644304 |e 910100PP132644304 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 999 | |a KXP-PPN1677699833 |e 3517880574 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"February 2019"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"pubHistory":["1.1989 -"],"part":{"volume":"31","extent":"11","pages":"230-240","year":"2019","issue":"2","text":"31(2019), 2, Seite 230-240"},"language":["eng"],"title":[{"title_sort":"European journal of gastroenterology & hepatology","subtitle":"official journal of the European Association for Gastroenterology and Endoscopy","title":"European journal of gastroenterology & hepatology"}],"recId":"324743343","note":["Gesehen am 20.05.14"],"origin":[{"publisherPlace":"Hagerstown, Md. ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1989","publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedDisp":"1989-"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals results from the German Hepatitis C-RegistryEuropean journal of gastroenterology & hepatology","id":{"zdb":["2030291-5"],"eki":["324743343"],"issn":["1473-5687"]},"physDesc":[{"extent":"Online-Ressource"}]}],"id":{"eki":["1677699833"],"doi":["10.1097/MEG.0000000000001283"]},"language":["eng"],"title":[{"title":"Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals","subtitle":"results from the German Hepatitis C-Registry","title_sort":"Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals"}],"recId":"1677699833","note":["Gesehen am 29.11.2019"],"name":{"displayForm":["Kathrin Krüger, Christian Krauth, Siegbert Rossol, Stefan Mauss, Klaus Boeker, Tobias Müller, Hartwig Klinker, Anita Pathil, Renate Heyne, Jona Stahmeyer, and Collaborators DHC-R"]},"person":[{"roleDisplay":"VerfasserIn","role":"aut","family":"Krüger","given":"Kathrin","display":"Krüger, Kathrin"},{"family":"Pathil-Warth","given":"Anita","display":"Pathil-Warth, Anita","role":"aut","roleDisplay":"VerfasserIn"}],"physDesc":[{"extent":"11 S."}]} | ||
| SRT | |a KRUEGERKATOUTCOMESAN2019 | ||